Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Indirect Calorimetry-Guided Nutritional Support in Mechanically Ventilated Children (CALI-PED) (CALI-PED)

10 listopada 2026 zaktualizowane przez: University Hospital, Montpellier

Use of Indirect Calorimetry to Guide Caloric Intake in Children on Mechanical Ventilation in the Pediatric Intensive Care Unit: A Prospective Comparative Study

Adequate nutritional support is essential in critically ill children receiving invasive mechanical ventilation. Current nutritional prescriptions are commonly based on predictive equations, which may inaccurately estimate individual energy requirements and contribute to underfeeding or overfeeding.

CALI-PED is a single-center, prospective, interventional pilot study designed to evaluate whether indirect calorimetry-guided nutritional support reduces interindividual variability in energy intake adequacy among mechanically ventilated children in the pediatric intensive care unit (PICU).

Fifty children will be prospectively enrolled and compared with a historical cohort of 141 patients managed using conventional nutritional targets based on the Schofield predictive equation. In the prospective cohort, resting energy expenditure will be measured daily using indirect calorimetry, for up to seven days of invasive mechanical ventilation, and enteral caloric prescriptions will be adjusted accordingly.

The primary outcome is the interindividual variability in the ratio of actual energy intake to the reference energy target on days 2 and 3 of mechanical ventilation. Secondary outcomes include protein intake, agreement between predicted and measured energy requirements, changes in resting energy expenditure over time, duration of mechanical ventilation, PICU length of stay, and incidence of nosocomial infections.

This pilot study aims to determine whether indirect calorimetry can improve the individualization and consistency of nutritional support in critically ill children.

Przegląd badań

Szczegółowy opis

**Background and Rationale** Nutritional support is a key component of pediatric intensive care. Inadequate nutritional intake has been associated with prolonged mechanical ventilation, increased nosocomial infections, longer intensive care and hospital stays, and higher mortality.

Current international guidelines recommend early nutritional assessment and suggest indirect calorimetry as the preferred method for determining resting energy expenditure (REE). However, nutritional prescriptions in routine clinical practice frequently rely on predictive equations, particularly the Schofield equation, which may not accurately reflect the metabolic requirements of critically ill children.

A previous retrospective study conducted in our PICU, involving 141 mechanically ventilated children, demonstrated persistent variability in energy intake on days 2 and 3 despite the implementation of a standardized enteral nutrition protocol. These findings suggest that individualizing energy targets using directly measured REE could improve nutritional adequacy.

**Study Design and Population** CALI-PED is a single-center, prospective, non-randomized, interventional pilot study conducted at Montpellier University Hospital, France.

The prospective cohort will include 50 children younger than 18 years, weighing at least 10 kg, receiving invasive mechanical ventilation through a cuffed endotracheal tube, with an expected ventilation duration exceeding 48 hours.

The prospective cohort will be compared with a previously collected historical cohort of 141 mechanically ventilated children managed using conventional nutritional targets based on the Schofield predictive equation.

**Intervention** In the prospective cohort, REE will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit.

Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Before each measurement, respiratory settings must have remained unchanged for at least one hour. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period.

Daily enteral energy prescriptions will be adjusted according to the measured REE, expressed in kcal/day and kcal/kg/day.

**Primary Outcome** The primary outcome is the interindividual dispersion of the ratio between actual energy intake and the reference energy target on days 2 and 3 of mechanical ventilation.

The reference energy target will be defined as:

  • Measured REE obtained by indirect calorimetry in the prospective cohort.
  • Estimated energy requirements calculated using the Schofield equation in the historical cohort.

Interindividual dispersion will be assessed using the interquartile range and coefficient of variation.

**Secondary Outcomes**

Secondary outcomes include:

  • Comparison of protein intake (g/kg/day) between cohorts on days 2 and 3.
  • Comparison of Schofield-predicted energy requirements with indirect calorimetry-measured REE in the prospective cohort.
  • Description of daily changes in measured REE during invasive mechanical ventilation, up to day 7.
  • Exploratory comparison of mechanical ventilation duration, PICU length of stay, and incidence of nosocomial infections between cohorts.

Nosocomial infections will be defined as infections occurring at least 48 hours after admission, according to Centers for Disease Control and Prevention criteria.

**Statistical Analysis** The distributions of energy intake adequacy ratios will be compared between the prospective and historical cohorts using appropriate statistical methods. Normality will be assessed using the Shapiro-Wilk test, and continuous variables will be compared using parametric or non-parametric tests as appropriate.

Additional analyses may account for differences between the prospective and historical cohorts, including propensity score methods.

Clinical outcomes will be considered exploratory, as the study is not powered to demonstrate differences in clinical endpoints.

**Study Duration and Ethical Considerations** The recruitment period is expected to last 30 months. Participants will be followed until PICU discharge or day 28 after inclusion, whichever occurs first.

The study was approved by the Comité de Protection des Personnes Île-de-France VII on August 5, 2026 (reference 26.02032.000560). Written informed consent will be obtained from at least one parent or legal guardian, and assent will be obtained from the child whenever feasible.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

50

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Lokalizacje studiów

    • Occitanie
      • Montpellier, Occitanie, Francja, 34295
        • Montpellier University Hospital - Arnaud de Villeneuve Hospital
        • Kontakt:
        • Główny śledczy:
          • Arthur Gavotto, MD, PhD

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

1 sekunda do 17 lat (Dziecko)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Children younger than 18 years of age.
  • Body weight ≥10 kg.
  • Invasive mechanical ventilation.
  • Expected duration of invasive mechanical ventilation >48 hours.
  • Child's assent to participate, whenever feasible.
  • Written informed consent obtained from at least one parent or legal guardian.

Exclusion Criteria:

  • Limitation or withdrawal of life-sustaining treatment planned at the time of admission to the pediatric intensive care unit.
  • Brain death.
  • Requirement for a specific dietary regimen due to an underlying condition, including diabetic ketoacidosis or an inherited metabolic disorder.
  • Gastrointestinal disorders interfering with enteral nutrition, including short bowel syndrome or malabsorption.
  • Participation in another research study with an ongoing exclusion period.
  • Concurrent participation in another interventional clinical trial that could interfere with the present study.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie podtrzymujące
  • Przydział: Nie dotyczy
  • Model interwencyjny: Zadanie dla jednej grupy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Indirect Calorimetry-Guided Nutrition

Fifty mechanically ventilated children will receive individualized enteral nutritional support guided by daily indirect calorimetry measurements. Resting energy expenditure will be measured from day 2 until extubation, for a maximum of seven days, and enteral caloric prescriptions will be adjusted accordingly.

Resting energy expenditure (REE) will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit. Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period. Daily enteral caloric prescriptions will be adjusted according to the measured REE.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Interindividual Variability in Energy Intake Adequacy on Days 2 and 3 of Mechanical Ventilation
Ramy czasowe: Days 2 and 3 of invasive mechanical ventilation

Interindividual variability in the ratio of actual energy intake (kcal/kg/day) to the reference energy target will be compared between the prospective and historical cohorts on days 2 and 3 of mechanical ventilation.

The reference energy target is defined as resting energy expenditure measured by indirect calorimetry in the prospective cohort and energy requirements estimated using the Schofield equation in the historical cohort.

Interindividual variability will be primarily quantified using the interquartile range (IQR) of the energy intake adequacy ratio. The coefficient of variation (CV) will be calculated as a complementary measure of dispersion.

Days 2 and 3 of invasive mechanical ventilation

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Daily Protein Intake on Days 2 of Mechanical Ventilation
Ramy czasowe: Days 2 of invasive mechanical ventilation

Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 2 of invasive mechanical ventilation.

Days 2 of invasive mechanical ventilation
Daily Protein Intake on Days 3 of Mechanical Ventilation
Ramy czasowe: Days 3 of invasive mechanical ventilation

Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 3 of invasive mechanical ventilation.

Days 3 of invasive mechanical ventilation
Difference Between Predicted and Measured Resting Energy Expenditure
Ramy czasowe: Days 2 to 7 of invasive mechanical ventilation

Difference between energy requirements estimated using the Schofield predictive equation and resting energy expenditure measured by indirect calorimetry in the prospective cohort, expressed in kcal/day.

Days 2 to 7 of invasive mechanical ventilation
Daily Changes in Measured Resting Energy Expenditure
Ramy czasowe: Days 2 to 7 of invasive mechanical ventilation

Daily resting energy expenditure measured by indirect calorimetry, expressed in kcal/day, will be described from day 2 until extubation, for a maximum of seven days of invasive mechanical ventilation, in the prospective cohort.

Days 2 to 7 of invasive mechanical ventilation
Duration of Invasive Mechanical Ventilation
Ramy czasowe: From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment

Duration of invasive mechanical ventilation, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome.

From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment
Pediatric Intensive Care Unit Length of Stay
Ramy czasowe: From PICU admission until PICU discharge, assessed up to day 28 after enrollment

Length of stay in the pediatric intensive care unit, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome.

From PICU admission until PICU discharge, assessed up to day 28 after enrollment
Incidence of Nosocomial Infections
Ramy czasowe: From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first

Proportion of patients developing at least one nosocomial infection, defined as an infection occurring at least 48 hours after PICU admission according to Centers for Disease Control and Prevention criteria. This exploratory clinical outcome will be compared between the prospective and historical cohorts.

From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Arthur Gavotto, University Hospital, Montpellier

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 stycznia 2027

Zakończenie podstawowe (Szacowany)

1 czerwca 2029

Ukończenie studiów (Szacowany)

1 lipca 2029

Daty rejestracji na studia

Pierwszy przesłany

10 listopada 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

10 listopada 2026

Pierwszy wysłany (Rzeczywisty)

17 listopada 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

17 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

10 listopada 2026

Ostatnia weryfikacja

1 listopada 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Opis planu IPD

Individual participant data will not be made publicly available due to the sensitive nature of clinical information collected from critically ill pediatric patients and applicable data protection requirements. Study results will be disseminated through scientific publications and presentations in aggregated form.

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj